Literature DB >> 1065266

Isolation of bacteriophages specific for the genus Veillonella.

H Hiroki, J Shiiki, A Handa, M Totsuka, O Nakamura.   

Abstract

Entities:  

Mesh：

Year:  1976        PMID： 1065266     DOI： 10.1016/0003-9969(76)90132-1

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN： 0003-9969            Impact factor:   2.633


× No keyword cloud information.
  6 in total

1.  Isolation of a novel bacteriophage specific for the periodontal pathogen Fusobacterium nucleatum.

Authors:  Pamela Machuca; Leslie Daille; Enrique Vinés; Liliana Berrocal; Mauricio Bittner
Journal:  Appl Environ Microbiol       Date:  2010-09-17       Impact factor: 4.792

2.  Use of lytic bacteriophage for Actinomyces viscosus T14V as a probe for cell surface components mediating intergeneric coaggregation.

Authors:  A L Delisle; J A Donkersloot; P E Kolenbrander; C A Tylenda
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

3.  Phage-receptor on the cell wall of Veillonella rodentium.

Authors:  M Totsuka
Journal:  Antonie Van Leeuwenhoek       Date:  1988       Impact factor: 2.271

4.  Purification and characterization of bacteriophage receptor on Veillonella rodentium cells. Phage-receptor on Veillonella.

Authors:  M Totsuka; T Ono
Journal:  Antonie Van Leeuwenhoek       Date:  1989-10       Impact factor: 2.271

5.  Exploitation of a Bacterium-Encoded Lytic Transglycosylase by a Human Oral Lytic Phage To Facilitate Infection.

Authors:  Lujia Cen; Yunjie Chang; Joseph K Bedree; Yansong Ma; Qiu Zhong; Daniel R Utter; Pu-Ting Dong; Renate Lux; Batbileg Bor; Jun Liu; Jeffrey S McLean; Shuai Le; Xuesong He
Journal:  J Virol       Date:  2022-08-24       Impact factor: 6.549

6.  Identification of Novel Bacteriophages with Therapeutic Potential That Target Enterococcus faecalis.

Authors:  M Al-Zubidi; M Widziolek; E K Court; A F Gains; R E Smith; K Ansbro; A Alrafaie; C Evans; C Murdoch; S Mesnage; C W I Douglas; A Rawlinson; G P Stafford
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.